Anti-recurrence Treatment of Postresection on HCC Patients With MVI Presence and Over-expression of ASPH

NCT02587884 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

180

Enrollment

OTHER

Sponsor class

Conditions

Hepatocellular Carcinoma

Interventions

PROCEDURE: TACE

Sponsor

Eastern Hepatobiliary Surgery Hospital